세계의 의료비 환급 시장(2024-2031년) : 시장 규모, 점유율 및 동향 분석(청구별, 서비스 제공업체별, 지불자별), 지역별 전망 및 예측
Global Healthcare Reimbursement Market Size, Share & Trends Analysis Report By Claim (Underpaid and Full Paid), By Service Provider, By Payer (Public Payers and Private Payers), By Regional Outlook and Forecast, 2024 - 2031
상품코드:1655216
리서치사:KBV Research
발행일:2025년 02월
페이지 정보:영문 187 Pages
라이선스 & 가격 (부가세 별도)
한글목차
의료비 환급 시장 규모는 예측 기간 중에 17.6%의 연평균 복합 성장률(CAGR)로 성장하여 2031년까지 808억 6,000만 달러에 달할 것으로 예상되고 있습니다.
의료업계에서는 사기가 만연하고 있기 때문에 보험회사와 의료제공업체는 사기방지와 규제 준수 노력에 많은 투자를 해야 합니다. 이로 인해 비용이 증가하고 환급 시스템이 더욱 복잡해집니다. 사기나 부정 청구에 대항하기 위한 규제의 노력은 개선되고 있지만, 이러한 문제는 여전히 시장 성장에 큰 장벽이 되고 있습니다. 이 문제를 해결하기 위해 의료 조직은 AI 및 머신러닝과 같은 기술 중심의 솔루션에 점점 더 눈길을 돌리고 부정 행위를 실시간으로 감지하고 방지하고 있지만, 이 문제는 여전히 심각한 우려 사항입니다. 따라서 의료 사기와 부정 청구는 시장 성장을 방해합니다.
청구별 전망
청구에 따라 시장은 분할 청구와 일괄 청구로 분류됩니다. 분할 청구 부문은 2023년 시장에서 최고 수익 점유율인 78%를 획득했습니다. 이 부문에는 의료 제공업체가 실제 비용 또는 계약 금액보다 낮은 비율로 서비스를 환급하는 경우가 포함됩니다. 할부금의 만연은 보험 청구 거부, 자금 부족 건강 프로그램 및 환급 지연으로 초래될 수 있습니다. 의료 제공업체는 운영 비용의 상승과 환불 문제에 의해 재정적 압력에 계속 노출되기 때문에 분할 청구 부문은 청구의 비효율성을 해결하고 지불의 정확성을 향상시키는 것을 목표로 하는 업계 이해 관계자에게 여전히 중요한 초점입니다.
지불자별 전망
지급자를 기준으로 시장은 민간 지급자(민간 보험)와 공적 지급자(공적 보험)로 분류됩니다. 공적 지불자 부문은 2023년 시장에서 54%의 수익 점유율을 달성했습니다. 메디케어, 메디케이드 및 기타 주 운영 건강 보험 제도와 같은 정부 자금 프로그램을 포함한 공공 지급자는 광범위한 보상 범위 및 대규모 수혜자 기반을 통해 의료비 환급 상황을 지배합니다. 고령화 인구 증가와 의료 요구 증가로 공공 지급자 프로그램의 확대가 촉진되고 있습니다. 게다가, 의료 서비스에 대한 접근성을 개선하기 위한 정책의 이행은 시장에서 공공 지급자의 존재감을 더욱 증가시키고 있습니다.
서비스 제공업체별 전망
서비스 제공업체별로 보면, 시장은 병원, 진료소(개원의), 진단 연구소, 기타로 나누어져 있습니다. 진료소 부문은 2023년 시장에서 20%의 수익 점유율을 달성했습니다. 개인 진료소와 그룹 진료소를 포함한 진료소는 기본 의료 및 전문 의료 서비스의 중요한 공급자입니다. 이러한 진료소는 일상적인 의료 수요와 예방 관리에 필수적이며, 종종 보다 빈번한 환급 청구로 이어집니다. 외래 진료 및 원격 의료로의 전환과 보험 가입자 수 증가는 진료소 부문에 긍정적인 영향을 미치고 의료비 환급 시장의 상당 부분을 차지하는 결과로 이어졌습니다.
지역별 전망
지역별로 보면 시장은 북미, 유럽, 아시아태평양, 라틴아메리카, 중동, 아프리카에 걸쳐 분석되고 있습니다. 북미 부문은 2023년 시장에서 52%의 수익 점유율을 기록했습니다. 북미, 특히 미국은 메디케어, 메디케이드, 고용주 주도 건강보험 등 광범위한 민간 및 공적 지급 프로그램을 갖춘 고도로 발달된 의료 시스템을 갖추고 있습니다. 이 지역의 고급 의료 구조와 보험에 접근할 수 있는 대규모 인구는 시장에서 지배적인 지위에 기여하고 있습니다. 게다가 디지털 헬스 기술의 채용 증가와 의료 접근 개선을 목적으로 한 정책 개혁은 북미의 의료비 환급 시장의 성장을 더욱 지원합니다.
목차
제1장 시장 범위와 분석 수법
시장 정의
목적
시장 범위
세분화
분석 방법
제2장 시장 요람
주요 하이라이트
제3장 시장 개요
소개
개요
시장 구성과 시나리오
시장에 영향을 미치는 주요 요인
시장 성장 촉진요인
시장 성장 억제요인
시장 기회
시장 과제
Porter's Five Forces 분석
제4장 세계의 의료비 환급 시장 : 청구별
세계의 분할 청구 시장 : 지역별
세계의 일괄 청구 시장 : 지역별
제5장 세계의 의료비 환급 시장 : 서비스 제공업체별
세계의 병원 시장 : 지역별
세계의 진단 실험실 시장 : 지역별
세계의 진료소 시장 : 지역별
세계의 기타 서비스 제공업체 시장 : 지역별
제6장 세계의 의료비 환급 시장 : 지불자별
세계의 공적 지불자(공적 보험) 시장 : 지역별
세계의 민간 지불자(민간 보험) 시장 : 지역별
제7장 세계의 의료비 환급 시장 : 지역별
북미
북미의 의료비 환급 시장 : 국가별
미국
캐나다
멕시코
기타 북미
유럽
유럽의 의료비 환급 시장 : 국가별
독일
영국
프랑스
러시아
스페인
이탈리아
기타 유럽
아시아태평양
아시아태평양의 의료비 환급 시장 : 국가별
중국
일본
인도
한국
싱가포르
말레이시아
기타 아시아태평양
라틴아메리카, 중동 및 아프리카
라틴아메리카, 중동 및 아프리카의 의료비 환급 시장 : 국가별
브라질
아르헨티나
아랍에미리트(UAE)
사우디아라비아
남아프리카
나이지리아
기타 라틴아메리카, 중동 및 아프리카
제8장 기업 프로파일
United HealthCare Services, Inc
CVS Health Corporation(ActiveHealth Management, Inc)
Allianz Care(Allianz Group)
Reliance Nippon Life Insurance Company Limited
The Cigna Group
Elevance Health, Inc
Humana Inc
Molina Healthcare, Inc
Centene Corporation
MetLife, Inc
제9장 의료비 환급 시장의 필수 성공 조건
CSM
영문 목차
영문목차
The Global Healthcare Reimbursement Market size is expected to reach $80.86 billion by 2031, rising at a market growth of 17.6% CAGR during the forecast period.
The increasing adoption of government health programs and private insurance schemes, alongside the region's growing aging population and higher healthcare demands and rising healthcare expenditures across countries like China, India, and Japan have played a key role in the growth of this segment. Hence, the Asia Pacific segment witnessed 19% revenue share in the market in 2023. The rapid growth of healthcare infrastructure, expanding healthcare insurance coverage, have also contributed to the substantial revenue share of the Asia Pacific segment in the market.
The combination of an aging population and the rising incidence of chronic diseases places significant pressure on healthcare systems to adapt. Reimbursement models must reflect the changing demographics and provide coverage for long-term care, frequent doctor visits, and specialty treatments. The need to cater to these complex, ongoing healthcare needs drives innovation and growth in the healthcare reimbursement market, spurring the development of more flexible and comprehensive reimbursement systems. Additionally, as healthcare spending shifts toward chronic disease management, long-term care, and the elderly population, the focus on cost-effective reimbursement models becomes even more pressing. This has led to an emphasis on integrating technology to improve reimbursement accuracy, reduce overhead, and enhance patient outcomes. As the market grapples with escalating healthcare expenses, it becomes clear that reimbursement models will need to evolve to accommodate these growing financial pressures, pushing for further advancements in the sector. In conclusion, the increase in chronic diseases and rising healthcare costs and a focus on cost management drives the market's growth.
However, the prevalence of fraud in the healthcare industry forces insurers and providers to invest heavily in fraud prevention and compliance efforts. This raises costs and makes reimbursement systems more complex. While regulatory efforts to combat fraud and billing abuse are improving, these issues remain a significant barrier to market growth. To address this challenge, healthcare organizations are increasingly turning to technology-driven solutions, such as AI and machine learning, to detect and prevent fraudulent activities in real-time, but the issue remains a persistent concern. Thus, healthcare fraud and billing abuse are impeding the market's growth.
Claim Outlook
Based on claim, the market is characterized into underpaid and full paid. The underpaid segment garnered 78% the highest revenue share in the market in 2023. This segment includes cases where healthcare providers are reimbursed for services at rates lower than the actual cost or contracted amount. The prevalence of underpayment can be attributed to insurance claim denials, underfunded health programs, and reimbursement delays. As healthcare providers continue to experience financial pressure due to rising operational costs and reimbursement challenges, the underpaid segment remains a significant focus for industry stakeholders aiming to address billing inefficiencies and improve payment accuracy.
Payer Outlook
On the basis of payer, the market is classified into private payers and public payers. The public payers segment acquired 54% revenue share in the market in 2023. Public payers, which include government-funded programs such as Medicare, Medicaid, and other state-run health insurance schemes, dominate the healthcare reimbursement landscape due to their extensive coverage and large beneficiary base. The growing aging population and increasing healthcare needs have driven expanding public-payer programs. Additionally, implementing policies to improve access to healthcare services has further boosted the prominence of public payers in the market.
Service Provider Outlook
By service provider, the market is divided into hospitals, physician offices, diagnostic laboratories, and others. The physician office segment garnered 20% revenue share in the market in 2023. Physician offices, which include individual and group practices, are essential providers of primary care and specialized medical services. These offices are crucial in managing routine healthcare needs and preventive care, often leading to more frequent reimbursement claims. The shift toward outpatient care and telemedicine, along with the increasing number of insured individuals, has positively impacted the physician office segment, enabling it to capture a significant portion of the healthcare reimbursement market.
Regional Outlook
Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment recorded 52% revenue share in the market in 2023. North America, particularly the United States, has a highly developed healthcare system with extensive private and public payer programs such as Medicare, Medicaid, and employer-sponsored health plans. The region's advanced healthcare infrastructure and a large population with access to insurance coverage contribute to its dominant position in the market. Additionally, the increasing adoption of digital health technologies and policy reforms aimed at improving healthcare access further support the growth of the healthcare reimbursement market in North America.
List of Key Companies Profiled
United HealthCare Services, Inc.
Allianz Care (Allianz Group)
CVS Health Corporation (ActiveHealth Management, Inc.)
Nippon Life Insurance Company Limited
The Cigna Group
Elevance Health, Inc.
Humana Inc.
Molina Healthcare, Inc.
Centene Corporation
MetLife, Inc.
Global Healthcare Reimbursement Market Report Segmentation
By Claim
Underpaid
Full Paid
By Service Provider
Hospitals
Diagnostic Laboratories
Physician Office
Other Service Provider
By Payer
Public Payers
Private Payers
By Geography
North America
US
Canada
Mexico
Rest of North America
Europe
Germany
UK
France
Russia
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Singapore
Malaysia
Rest of Asia Pacific
LAMEA
Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Healthcare Reimbursement Market, by Claim
1.4.2 Global Healthcare Reimbursement Market, by Service Provider
1.4.3 Global Healthcare Reimbursement Market, by Payer
1.4.4 Global Healthcare Reimbursement Market, by Geography
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Global Healthcare Reimbursement Market by Claim
4.1 Global Underpaid Market by Region
4.2 Global Full Paid Market by Region
Chapter 5. Global Healthcare Reimbursement Market by Service Provider
5.1 Global Hospitals Market by Region
5.2 Global Diagnostic Laboratories Market by Region
5.3 Global Physician Office Market by Region
5.4 Global Other Service Provider Market by Region
Chapter 6. Global Healthcare Reimbursement Market by Payer
6.1 Global Public Payers Market by Region
6.2 Global Private Payers Market by Region
Chapter 7. Global Healthcare Reimbursement Market by Region
7.1 North America Healthcare Reimbursement Market
7.1.1 North America Healthcare Reimbursement Market by Claim
7.1.1.1 North America Underpaid Market by Region
7.1.1.2 North America Full Paid Market by Region
7.1.2 North America Healthcare Reimbursement Market by Service Provider
7.1.2.1 North America Hospitals Market by Country
7.1.2.2 North America Diagnostic Laboratories Market by Country
7.1.2.3 North America Physician Office Market by Country
7.1.2.4 North America Other Service Provider Market by Country
7.1.3 North America Healthcare Reimbursement Market by Payer
7.1.3.1 North America Public Payers Market by Country
7.1.3.2 North America Private Payers Market by Country
7.1.4 North America Healthcare Reimbursement Market by Country
7.1.4.1 US Healthcare Reimbursement Market
7.1.4.1.1 US Healthcare Reimbursement Market by Claim
7.1.4.1.2 US Healthcare Reimbursement Market by Service Provider
7.1.4.1.3 US Healthcare Reimbursement Market by Payer
7.1.4.2 Canada Healthcare Reimbursement Market
7.1.4.2.1 Canada Healthcare Reimbursement Market by Claim
7.1.4.2.2 Canada Healthcare Reimbursement Market by Service Provider
7.1.4.2.3 Canada Healthcare Reimbursement Market by Payer
7.1.4.3 Mexico Healthcare Reimbursement Market
7.1.4.3.1 Mexico Healthcare Reimbursement Market by Claim
7.1.4.3.2 Mexico Healthcare Reimbursement Market by Service Provider
7.1.4.3.3 Mexico Healthcare Reimbursement Market by Payer
7.1.4.4 Rest of North America Healthcare Reimbursement Market
7.1.4.4.1 Rest of North America Healthcare Reimbursement Market by Claim
7.1.4.4.2 Rest of North America Healthcare Reimbursement Market by Service Provider
7.1.4.4.3 Rest of North America Healthcare Reimbursement Market by Payer
7.2 Europe Healthcare Reimbursement Market
7.2.1 Europe Healthcare Reimbursement Market by Claim
7.2.1.1 Europe Underpaid Market by Country
7.2.1.2 Europe Full Paid Market by Country
7.2.2 Europe Healthcare Reimbursement Market by Service Provider
7.2.2.1 Europe Hospitals Market by Country
7.2.2.2 Europe Diagnostic Laboratories Market by Country
7.2.2.3 Europe Physician Office Market by Country
7.2.2.4 Europe Other Service Provider Market by Country
7.2.3 Europe Healthcare Reimbursement Market by Payer
7.2.3.1 Europe Public Payers Market by Country
7.2.3.2 Europe Private Payers Market by Country
7.2.4 Europe Healthcare Reimbursement Market by Country
7.2.4.1 Germany Healthcare Reimbursement Market
7.2.4.1.1 Germany Healthcare Reimbursement Market by Claim
7.2.4.1.2 Germany Healthcare Reimbursement Market by Service Provider
7.2.4.1.3 Germany Healthcare Reimbursement Market by Payer
7.2.4.2 UK Healthcare Reimbursement Market
7.2.4.2.1 UK Healthcare Reimbursement Market by Claim
7.2.4.2.2 UK Healthcare Reimbursement Market by Service Provider
7.2.4.2.3 UK Healthcare Reimbursement Market by Payer
7.2.4.3 France Healthcare Reimbursement Market
7.2.4.3.1 France Healthcare Reimbursement Market by Claim
7.2.4.3.2 France Healthcare Reimbursement Market by Service Provider
7.2.4.3.3 France Healthcare Reimbursement Market by Payer
7.2.4.4 Russia Healthcare Reimbursement Market
7.2.4.4.1 Russia Healthcare Reimbursement Market by Claim
7.2.4.4.2 Russia Healthcare Reimbursement Market by Service Provider
7.2.4.4.3 Russia Healthcare Reimbursement Market by Payer
7.2.4.5 Spain Healthcare Reimbursement Market
7.2.4.5.1 Spain Healthcare Reimbursement Market by Claim
7.2.4.5.2 Spain Healthcare Reimbursement Market by Service Provider
7.2.4.5.3 Spain Healthcare Reimbursement Market by Payer
7.2.4.6 Italy Healthcare Reimbursement Market
7.2.4.6.1 Italy Healthcare Reimbursement Market by Claim
7.2.4.6.2 Italy Healthcare Reimbursement Market by Service Provider
7.2.4.6.3 Italy Healthcare Reimbursement Market by Payer
7.2.4.7 Rest of Europe Healthcare Reimbursement Market
7.2.4.7.1 Rest of Europe Healthcare Reimbursement Market by Claim
7.2.4.7.2 Rest of Europe Healthcare Reimbursement Market by Service Provider
7.2.4.7.3 Rest of Europe Healthcare Reimbursement Market by Payer
7.3 Asia Pacific Healthcare Reimbursement Market
7.3.1 Asia Pacific Healthcare Reimbursement Market by Claim
7.3.1.1 Asia Pacific Underpaid Market by Country
7.3.1.2 Asia Pacific Full Paid Market by Country
7.3.2 Asia Pacific Healthcare Reimbursement Market by Service Provider
7.3.2.1 Asia Pacific Hospitals Market by Country
7.3.2.2 Asia Pacific Diagnostic Laboratories Market by Country
7.3.2.3 Asia Pacific Physician Office Market by Country
7.3.2.4 Asia Pacific Other Service Provider Market by Country
7.3.3 Asia Pacific Healthcare Reimbursement Market by Payer
7.3.3.1 Asia Pacific Public Payers Market by Country
7.3.3.2 Asia Pacific Private Payers Market by Country
7.3.4 Asia Pacific Healthcare Reimbursement Market by Country
7.3.4.1 China Healthcare Reimbursement Market
7.3.4.1.1 China Healthcare Reimbursement Market by Claim
7.3.4.1.2 China Healthcare Reimbursement Market by Service Provider
7.3.4.1.3 China Healthcare Reimbursement Market by Payer
7.3.4.2 Japan Healthcare Reimbursement Market
7.3.4.2.1 Japan Healthcare Reimbursement Market by Claim
7.3.4.2.2 Japan Healthcare Reimbursement Market by Service Provider
7.3.4.2.3 Japan Healthcare Reimbursement Market by Payer
7.3.4.3 India Healthcare Reimbursement Market
7.3.4.3.1 India Healthcare Reimbursement Market by Claim
7.3.4.3.2 India Healthcare Reimbursement Market by Service Provider
7.3.4.3.3 India Healthcare Reimbursement Market by Payer
7.3.4.4 South Korea Healthcare Reimbursement Market
7.3.4.4.1 South Korea Healthcare Reimbursement Market by Claim
7.3.4.4.2 South Korea Healthcare Reimbursement Market by Service Provider
7.3.4.4.3 South Korea Healthcare Reimbursement Market by Payer
7.3.4.5 Singapore Healthcare Reimbursement Market
7.3.4.5.1 Singapore Healthcare Reimbursement Market by Claim
7.3.4.5.2 Singapore Healthcare Reimbursement Market by Service Provider
7.3.4.5.3 Singapore Healthcare Reimbursement Market by Payer
7.3.4.6 Malaysia Healthcare Reimbursement Market
7.3.4.6.1 Malaysia Healthcare Reimbursement Market by Claim
7.3.4.6.2 Malaysia Healthcare Reimbursement Market by Service Provider
7.3.4.6.3 Malaysia Healthcare Reimbursement Market by Payer
7.3.4.7 Rest of Asia Pacific Healthcare Reimbursement Market
7.3.4.7.1 Rest of Asia Pacific Healthcare Reimbursement Market by Claim
7.3.4.7.2 Rest of Asia Pacific Healthcare Reimbursement Market by Service Provider
7.3.4.7.3 Rest of Asia Pacific Healthcare Reimbursement Market by Payer
7.4 LAMEA Healthcare Reimbursement Market
7.4.1 LAMEA Healthcare Reimbursement Market by Claim
7.4.1.1 LAMEA Underpaid Market by Country
7.4.1.2 LAMEA Full Paid Market by Country
7.4.2 LAMEA Healthcare Reimbursement Market by Service Provider
7.4.2.1 LAMEA Hospitals Market by Country
7.4.2.2 LAMEA Diagnostic Laboratories Market by Country
7.4.2.3 LAMEA Physician Office Market by Country
7.4.2.4 LAMEA Other Service Provider Market by Country
7.4.3 LAMEA Healthcare Reimbursement Market by Payer
7.4.3.1 LAMEA Public Payers Market by Country
7.4.3.2 LAMEA Private Payers Market by Country
7.4.4 LAMEA Healthcare Reimbursement Market by Country
7.4.4.1 Brazil Healthcare Reimbursement Market
7.4.4.1.1 Brazil Healthcare Reimbursement Market by Claim
7.4.4.1.2 Brazil Healthcare Reimbursement Market by Service Provider
7.4.4.1.3 Brazil Healthcare Reimbursement Market by Payer
7.4.4.2 Argentina Healthcare Reimbursement Market
7.4.4.2.1 Argentina Healthcare Reimbursement Market by Claim
7.4.4.2.2 Argentina Healthcare Reimbursement Market by Service Provider
7.4.4.2.3 Argentina Healthcare Reimbursement Market by Payer
7.4.4.3 UAE Healthcare Reimbursement Market
7.4.4.3.1 UAE Healthcare Reimbursement Market by Claim
7.4.4.3.2 UAE Healthcare Reimbursement Market by Service Provider
7.4.4.3.3 UAE Healthcare Reimbursement Market by Payer
7.4.4.4 Saudi Arabia Healthcare Reimbursement Market
7.4.4.4.1 Saudi Arabia Healthcare Reimbursement Market by Claim
7.4.4.4.2 Saudi Arabia Healthcare Reimbursement Market by Service Provider
7.4.4.4.3 Saudi Arabia Healthcare Reimbursement Market by Payer
7.4.4.5 South Africa Healthcare Reimbursement Market
7.4.4.5.1 South Africa Healthcare Reimbursement Market by Claim
7.4.4.5.2 South Africa Healthcare Reimbursement Market by Service Provider
7.4.4.5.3 South Africa Healthcare Reimbursement Market by Payer
7.4.4.6 Nigeria Healthcare Reimbursement Market
7.4.4.6.1 Nigeria Healthcare Reimbursement Market by Claim
7.4.4.6.2 Nigeria Healthcare Reimbursement Market by Service Provider
7.4.4.6.3 Nigeria Healthcare Reimbursement Market by Payer
7.4.4.7 Rest of LAMEA Healthcare Reimbursement Market
7.4.4.7.1 Rest of LAMEA Healthcare Reimbursement Market by Claim
7.4.4.7.2 Rest of LAMEA Healthcare Reimbursement Market by Service Provider
7.4.4.7.3 Rest of LAMEA Healthcare Reimbursement Market by Payer
Chapter 8. Company Profiles
8.1 United HealthCare Services, Inc.
8.1.1 Company Overview
8.2 CVS Health Corporation (ActiveHealth Management, Inc.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.3 Allianz Care (Allianz Group)
8.3.1 Company Overview
8.3.2 Financial Analysis
8.4 Reliance Nippon Life Insurance Company Limited
8.4.1 Company Overview
8.5 The Cigna Group
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental Analysis
8.6 Elevance Health, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental Analysis
8.7 Humana Inc.
8.7.1 Company Overview
8.8 Molina Healthcare, Inc.
8.8.1 Company Overview
8.9 Centene Corporation
8.9.1 Company Overview
8.10. MetLife, Inc.
8.10.1 Company Overview
Chapter 9. Winning Imperatives of Healthcare Reimbursement Market